Institut de Duve Avenue Hippocrate 74 - B1.75.08 1200 Bruxelles
The Bommer Lab's aim is to reveal novel metabolic mechanisms underlying the development of human diseases ranging from cancer to neurodegeneration.
Exploring the Intricacies of Cellular Metabolism: Unveiling new mechanisms of disease.
At the core of life lie chemical reactions that we collectively call metabolism. Enzymes drive most of these reactions, organized into pathways that were discovered in the past century. While textbooks imply we've uncovered all cellular metabolic enzymes, reality differs: Enzymes with unknown functions remain, and some enzyme roles have been misinterpreted. Additionally, certain chemical reactions occur without enzymes, yet significantly impacting human health and aging.
Guido Bommer and his team are dedicated to investigating these lesser-known aspects of cellular metabolism, uncovering novel mechanisms behind various human diseases, ranging from cancer to neurodegeneration. Their approach combines mass spectrometry, genetics, and classical enzymology techniques. While their research often starts with a specific idea, projects sometimes take unexpected turns, leading to findings far from the initial hypotheses.
Recently, this has led to the elucidation of the biogenesis of novel post-translational modifications involved in neuromuscular diseases (i.e. ribitolphosphorylation) and Parkinson's disease (i.e. N-glyceroylation and N-phosphoglyceroylation).
Guido Bommer graduated in Medicine from the University of Munich, Germany. After some time in clinical practice and a research fellowship in the laboratory of Eric Fearon at the University of Michigan, he obtained a PhD at the Université Catholique de Louvain. Since 2011, he is a permanent researcher of the Belgian National Research Fund (FNRS) and Professor at UCLouvain, Brussels. Between 2021 and 2023, he was visiting Professor at the University of Parma, and in 2022 he held the Bauchau Chair at the University of Namur. His lab is generously supported by (among others) a WELBIO Starting Grant and an ERC Consolidator Grant.
Wilson MP, Kentache T, Althoff CR, Schulz C, de Bettignies G, Mateu Cabrera G, Cimbalistiene L, Burnyte B, Yoon G, Costain G, Vuillaumier-Barrot S, Cheillan D, Rymen D, Rychtarova L, Hansikova H, Bury M, Dewulf JP, Caligiore F, Jaeken J, Cantagrel V, Van Schaftingen E, Matthijs G, Foulquier F, Bommer GT
Cell (2024) S0092-8674(24)00467-7
Heremans IP, Caligiore F, Gerin I, Bury M, Lutz M, Graff J, Stroobant V, Vertommen D, Teleman AA, Van Schaftingen E, Bommer GT.
Proc Natl Acad Sci U S A (2022) 119(4): e2111338119.
Collard F, Baldin F, Gerin I, Bolsée J, Noël G, Graff J, Veiga-da-Cunha M, Stroobant V, Vertommen D, Houddane A, Rider MH, Linster CL, Van Schaftingen E, Bommer GT.
Nat Chem Biol (2016) 12(8):601-607.
Gerin I, Ury B, Breloy I, Bouchet-Seraphin C, Bolsée J, Halbout M, Graff J, Vertommen D, Muccioli GG, Seta N, Cuisset J-M, Dabaj I, Quijano-Roy S, Grahn A, Van Schaftingen E, Bommer GT.
Nat Comm (2016) 19:11534.